Related Experiment Video
Updated: Aug 22, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
The determinants of Chagas disease: connecting parasite and host genetics
David A Campbell1, Scott J Westenberger, Nancy R Sturm
1Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095-1489, USA. dc@ucla.edu
Insights
Chagas disease, caused by Trypanosoma cruzi, involves complex host-parasite interactions. Understanding these interactions is key to developing better treatments for chronic Chagas disease.
Area of Science:
- Parasitology
- Immunology
- Genetics
Background:
- Chagas disease affects 30% of Trypanosoma cruzi infected individuals, causing chronic conditions like cardiomyopathy.
- Disease outcome results from intricate interactions between host genetics, environment, parasite genetics, and co-infections.
Purpose of the Study:
- To review the genetic structure and biological properties of Trypanosoma cruzi.
- To examine host factors influencing susceptibility and resistance to Chagas disease.
- To highlight the need for integrating host-pathogen interaction research for improved treatment.
Main Methods:
- Analysis of Trypanosoma cruzi genetic subgroups and genotypic classes.
- Review of human and experimental models (mouse infection, tissue culture) for host-parasite interactions.
- Exploration of genetic exchange mechanisms in the parasite.
Main Results:
- Six distinct Trypanosoma cruzi subgroups identified.
- Genetic exchange via non-meiotic cell fusion demonstrated, potentially explaining parasite polyploidy.
- Host genetic background and parasite composition significantly influence disease progression.
Conclusions:
- Understanding host-pathogen interactions is crucial for developing clinical treatments for Chagas disease.
- Integrating diverse research areas is essential for better prognosis and treatment strategies.
- Further research into host-pathogen interplay promises improved clinical outcomes.
Abstract:
As a consequence of infection by Trypanosoma cruzi, 30% of victims may develop chronic Chagas disease, which presents a spectrum of pathology including cardiomyopathy, megacolon and megaesophagus. The outcome of infection in a particular individual is the result of a set of complex interactions among the host genetic background, environmental and social factors, and the genetic composition of the parasite, all of which can be complicated by mixed infections and re-infections. Initially we consider what is known about the genetic structure and biological properties of the protozoan. Currently, six distinct subgroups have been characterized by different combinations of four distinct genotypic classes. The recent demonstration of genetic exchange via non-meiotic cell fusion illustrates a mechanism by which maintained heterogeneous polyploidy may have been generated in these parasites. Subsequently, we consider factors in humans and in experimental mouse-infection and tissue culture models that have contributed to our understanding of the host's susceptibility or resistance to disease. Identification of the direct players in host-pathogen interactions at the establishment and chronic phases of the disease is perhaps the best hope of a clinical handle for treatment. At some point in the future, these disparate areas of study will have to come together. It is to be hoped that this scientific fusion will result in better prognosis and treatment of Chagas disease.
Related Concept Videos
American Trypanosomiasis
Malaria
Toxoplasmosis
Amebiasis
Leishmaniasis
Incomplete Dominance

